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1. Introduction 
The diseases of the nose and paranasal sinuses are among the most commonly identified 
causes of chronic cough (Pratter, 2006). Depending on the population studied and the 
variations in diagnostic algorithm, the diseases of nose and sinuses are reported to 
contribute to coughing in 20–40% of patients with chronic cough who have normal chest 
radiograph (Chung & Pavord, 2008). The mechanisms of chronic cough in rhinosinusitis are 
incompletely understood. Several mechanisms have been proposed, single or in 
combination: upper airway cough syndrome previously postnasal drip (PND), direct 
irritation, inflammation in the lower airways and the cough reflex sensitization (Pratter, 
2006). 
2. Cough 
Cough has been described as the ´watchdog of the lungs´. Its onset is almost always 
associated with peripheral stimulation; this is indicative of its reflex character (Korpas & 
Tomori, 1979). Cough is mostly an infrequent and physiological act in where its functions are 
to protect against aspiration and clearing bronchial excretions along with removal of 
infective and foreign substances that find their way in the respiratory tract. This happens as 
a reflective act, though cough may also be a voluntary action. When cough occur more 
frequent and persist, it is usually a cardinal sign of respiratory disease. In this situation 
protective systems fail or collapse due to overloading of foreign substances or excessive 
bronchial excretions and to compensate this breakdown cough frequency increases. The 
action of cough can be divided into three phases: inspiratory, compressive and expulsive 
(Coryllos, 1937; Korpas & Tomori, 1979). Cough is a defensive reflex that protects the airways 
from inhaling potentially damaging particles, aeroallergens, pathogens, aspirate and 
secretions accumulated (Mazzone et al., 2003). Like any other reflex process, cough is effected 
by means of a reflex arc, which is composed of five basic links: receptors, an afferent 
pathway, a centre, an efferent pathway and effectors (Korpas & Tomori, 1979). 
2.1 Airway afferent and receptors 
The airway afferent nerve fibers may be divided into several subtypes based on their 
physicochemical sensitivity, adaptation to sustained lung inflation, neurochemistry, origin, 
myelination, conduction velocity and sites of termination in the airways (Mazzone et al., 
2003). The lack of specificity and characteristics for each of these subgroups has made the 
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study and to define them separately quite difficult. By gross dividing, however, these 
physiological and morphological attributes can be used to identify at least three broad 
classes of afferent nerve fibers: rapidly adapting mechanoreceptors (RARs), slowly adapting 
mechanoreceptors (SARs) and unmyelinated C-fibers (C-fibers) (Mazzone et al., 2003). 
2.1.1 Rapidly adapting receptors (RARs) 
While the anatomical arrangement of RARs termination is unknown, functional studies 
suggest that these receptors terminate within or beneath the epithelium and are localized to 
both intra- and extrapulmonary airways (Bergren & Sampson, 1982; Riccio et al., 1996c, Ho et 
al., 2001). RARs, as its name implies, is differentiated from the other airway afferent nerves 
by their rapid (1-2sec) adaptation to sustained lung inflations (Armstrong & Luck 1974; 
Coleridge & Coleridge, 1984; Ho et al., 2001; Sant´Ambrogio & Widdicombe, 2001; Widdicombe, 
2001). Other distinguishing properties of RARs include their sensitivity to lung collapse 
and/or lung deflation, their responsiveness to alterations in dynamic lung compliance (thus 
their sensitivity to bronchospasm), and theirs conduction velocity (4-18m/sec), suggestive of 
small myelinated axons (Bergren & Sampson, 1982; Jonzon et al., 1986; Riccio et al., 1996; Ho et 
al., 2001; Widdicombe, 2001). Analysis has shown that sustained activation of RARs produced 
by dynamic lung inflation, bronchospasm or lung collapse is not attributable to an 
electrophysiological adaptation (Bergren & Sampson 1982; Pack & DeLaney, 1983; McAlexander 
et al., 1999; Ho et al., 2001). Maybe a more suitable name for better defining RARs are 
dynamic receptors that respond to changes in airway mechanical properties (e.g., diameter, 
length, interstitial pressures). 
The dynamic mechanical forces accompanying lung inflation and deflation sporadically 
activates RARs throughout the respiratory cycle and becomes more active as the rate of lung 
inflation increase (Pack & DeLaney 1983; McAlexander et al., 1999; Ho et al., 2001). This means 
that the RARs activity during respiration is connected to respiratory rate and is higher in 
small animals, while in larger animals, it would be almost unmeasurable. In the smaller 
animals, RARs-dependent reflexes will also require a heightened activity in the already 
active RARs.  
Even though RARs may be insensitive to ´direct´ chemical stimuli, stimuli from 
bronchospasm or obstruction due to mucus secretion or oedema can increase the RAR 
activity (Mohammed et al., 1993; Bonham et al., 1996; Bergren, 1997; Joad et al., 1997; Canning et 
al., 2001; Widdicombe, 2001). By preventing the local end-organ effects that is stimulated by 
substances such as histamine, capsaicin, substance P and bradykinin, activation of RARs can 
be markedly inhibited or abolished (Mazzone et al., 2003). Stimuli that evoke cough react 
RARs and RARs fullfill many of the accepted criteria for mediating cough (Sant´Ambrogio et 
al., 1984; Canning et al., 2000; Sant´Ambrogio & Widdicombe, 2001; Widdicombe 2001). Studies of 
vagal cooling have shown further evidence of RARs role in the cough reflex, that block 
cough at temperatures that selectively abolish activity in myelinated fibers (including RARs) 
while preserving C-fiber activity (Widdicombe, 1974; Tatar et al., 1988; Tatar et al., 1994). 
2.1.2 Slowly adapting stretch receptors (SARs) 
SARs is equal to RARs in at they also are highly sensitive to the mechanical forces lungs deal 
with during breathing. SARs, however, differentiate from RARs in that their activity 
increases sharply during inspiratory phase and peaks just before the initiation of expiration 
(Ho et al., 2001; Schelegle & Green, 2001), while RARs can be activated during both inflation 
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and deflation of the lung (including lung collapse) (Ho et al. 2001; Widdicombe, 2003). This 
makes it likely that SARs are the primary afferent fibers involved in the Hering-Breuer 
reflex, a reflex which ends inspiration and initiates expiration when the lungs are 
adequately inflated (Schelegle & Green, 2001). SARs also adapt more slowly to stimuli from 
sustained lung inflations, than, as the name implies, RARs demonstrate rapid adaption (Ho 
et al., 2001; Widdicombe, 2003). SARs may also be differently spread throughout the airways 
(Schelegle & Green, 2001). 
Evoking of reflexes is also done differently by SARs and RARs. Activation by SARs results 
in a reduction in airway tone due to inhibition of cholinergic drive to the airway smooth 
muscle (Canning et al., 2001). 
There is suggested after single-unit recordings from the vagus nerve in rabbits that activity 
of SARs neither increase before or during ammonia-induced coughing (Matsumoto, 1988). 
Even though this means that RARs do not play any big part in the cough reflex, RARs clear 
influence over the respiratiory pattern indicates that they do have a role in cough reflex. It is 
suggested that the usage of the loop diuretic frusemide (furosemide) will increase the 
baseline acitvity of RARs, and thereby account for the reported antitussive effects of this 
agent in animal and human subjects. Reports have shown that preloading, in contrast, that 
likely will increase baseline SARs activity, will increase expiratory efforts during cough 
(Hanacek & Korpas, 1982; Nishino et al., 1989). On the contrary, experiments on rabbits 
inhaling sulfur dioxide have been used in an attempt to selectively block SARs activity show 
that the cough reflex is coincidentally attenuated (Hanacek et al., 1984, Sant´Ambrogio et al., 
1984). This selectivity to sulfur dioxide for airway SARs is however questionable since 
several reports show that sulfur dioxide has an excitatory action on airway C-fibers (Atzori 
et al., 1992; Wang et al., 1996). 
Studies done on CNS processing has also suggested that cough may be facilitated by SARs. 
There is proposed that a central cough network in which SARs facilitate cough via activation 
of brainstem second-order neurons (pump cells) of the SARs reflex pathway (Shannon et al., 
1998).  
2.1.3 C-fibers 
C-fibers are unmyelinated afferent fibres which are similar to the unmyelinated nociceptors 
of the somatic nerve fibers both physiologically and morphologically, and these C-fibers 
constitute the majority of afferent nerves innervating the airways (Coleridge & Coleridge, 
1984; Ma & Woolf, 1995; Lee & Pisarri, 2001). Being unmyelinated differ their conduction 
velocity compared to RARs and SARs, but their relative insensitivity to mechanical 
stimulation, lung inflation and their responsiveness to bradykinin and capsaicin is also 
important differentiations (Armstrong & Luck, 1974; Riccio et al., 1996; Bergren, 1997; Ho et al., 
2001; Canning et al., 2001; Lee & Pisarri, 2001; Widdicombe, 2001). C-fibers also differ from the 
RARs in that bradykinin- and capsaicin-evoked activation of their endings in the airways is 
not inhibited by pre-treatment with bronchodilators. Oppositely, bronchodilators such as 
prostaglandin E2, adrenaline and adenosine may enhance excitability of airway afferent C-
fibers (Ho et al., 2000; Lee & Pisarri, 2001). By this, C- fibers differentiate from RARs in at their 
bronchopulmonary C-fibers are directly activated by substances like bradykinin and 
capsaicin.  
Studies on C-fibers has been done on many animals, and morphological studies on guinea-
pigs and rats have shown that C- fibers innervate the airway epithelium together with 
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effector structures within the airway wall (Lundberg et al., 1984; Baluk et al., 1992; Riccio et al., 
1996; Hunter & Undem, 1999). Several studies show a unique neurochemical property of the 
bronchopulmonary fibers has been used to illustrate the distribution and peripheral nerve 
terminals of the unmyelinated airway afferent nerve endings. These studies reveal that C-
fiber have the ability to synthesize neuropeptides that afterwards are transported to their 
central and peripheral nerve terminals (Baluk et al., 1992; Riccio et al., 1996c; Hunter & Undem, 
1999; Myers et al., 2002). Coleridge & Coleridge (1984) described in afferent vagal C-fiber 
innervations of the lungs and airways and its functional significance, that in dogs C-fibers 
may be further subdivided into bronchial and pulmonary fibers, a differentiation based on 
sites of termination and on responsiveness to chemical and mechanical stimuli. Based on 
this division, pulmonary C-fibers may be unresponsive to histamine, while bronchial C-
fibers are activated by histamine. This observation is made on dogs, and in whether the 
physiologic differences are similar in other species are still unknown, but recent studies 
have described C-fiber subtypes innervating in the intrapulmonary airways and lungs of 
mice and guinea pigs (Kollarik et al., 2003; Undem et al., 2003). C-fibers are believed to have an 
important role in airway reflexes. Even with their polygonal shape that made them respond 
to chemical and mechanical stimulation, compared to RARs and SARs, the threshold for 
mechanical stimulation is markedly increased (Matsumoto, 1988; Deep et al., 2001). As a 
consequence, C-fibers mostly lie latent throughout the respiratory cycle, but are easily 
activated by chemical stimuli such as capsaicin, bradykinin, citric acid, hypertonic saline, 
and sulphur dioxide (Riccio et al., 1996c; Ho et al., 2001; Widdicombe, 2001; Lee & Pisarri, 2001). 
Increased airway parasympathetic nerve activity and chemoreflex, characterized by apnea 
(followed by rapid shallow breathing), bradycardia, and hypotension are all reflex 
responses elicited by C- fiber activation (Coleridge & Coleridge, 1984; Canning et al., 2001). In 
species like rats and guinea-pigs bronchospasm and neurogenic inflammation by C-fibre 
activation which elicit peripheral release of neuropeptides via an axon reflex (Barnes, 2001; 
Lee & Pisarri, 2001). 
The function of the C-fibers in the cough reflex is debatable. Many studies have given evidence 
to the hypothesis that C-fiber activation in the airways precipitate cough. In some cases there is 
believed that selective stimulants like capsaicin, bradykinin and citric acid evoke cough in 
conscious animals and humans (Coleridge & Coleridge, 1984; Forsberg & Karlsson, 1986; 
Mohammed et al., 1993; Karlsson, 1996; Mazzone et al., 2002). In addition, capsaicin is used in 
pretreatment when needed to selectively deplete C-fibers of neuropeptides, which abrogate 
cough in guinea-pigs induced by citric acid, but by evoking C-fibers by mechanical probing 
has no effect on cough (Forsberg & Karlsson, 1986). At last, pharmacological studies that take 
the advantage of the unique expression of neurokinins by the airway C-fibers, have shown 
that bradykinin-, citric acid-induced cough in cats and guinea-pigs is attenuated or abolished 
by neurokinin receptor antagonists (Bolser et al., 1997). 
All these evidences above indicate that C-fibers take part in the cough reflex. On the other 
hand, there are also evidences suggesting that C-fibers do not evoke cough and may instead 
inhibit cough by stimulation of RARs-fibers. For instance, in studies with anesthetized 
animals, C-fibre stimulation has consistently failed to evoke coughing, even though cough 
can be readily induced in these animals by mechanically probing mucosal sites along the 
airways (Tatar et al., 1988; Tatar et al., 1994; Canning et al., 2000; Deep et al., 2001). Systemic 
administration of C-fibre stimulants may in fact have been shown to inhibit cough evoked 
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by RARs stimulation in various species (Tatar et al., 1988; Tatar et al., 1994; Canning et al., 
2000). Further evidence supports the C-fibers role in inhibition of cough in that vagal 
cooling to temperatures that can maintain C-fiber-dependent reflexes can abolish cough 
(Tatar et al., 1994). 
The reason for these antagonistic evidences about C-fibers and cough are ambiguous. One 
reason may be that general anesthesia in animals selectively disrupt the ability of C-fibers to 
evoke cough without unfavourably affecting cough induced by stimulation of RARs. 
Nishino et al. (1996) studies of cough and the reflexes on irritation of airway mucosa in man 
show that general anesthesia has a profound influence over cough reflex. But there is 
unlikely that C-fibre activation and C-fibre-mediated reflex are entirely prevented by 
anesthesia (Roberts et al., 1981; Coleridge & Coleridge, 1984; Bergren 1997; Canning et al., 2001). 
So, action by anesthesias on C-fibers may either work by setting off cough activation by the 
inhibitory effects of C-fiber or it must selectively inhibit cough-related natural pathways. As 
an alternative, general anesthesia might actually intervene with the conscious perception of 
airway irritation and thereby interfere with the subjects urge to cough. One interesting fact 
of this circumstance is that capsaicin-evoked cough can be consciously suppressed in 
humans tested (Hutchings et al., 1993) Despite a lot of studies, there is still an equally 
possible hypothesis that C-fibre stimulation alone is too insufficient to evoke cough but are 
dependent on the airway afferent interactions in both the periphery and the level of CNS 
(Canning & Mazzone, 2005). 
2.2 Central regulation of cough 
Studies have come a long way in understanding the central mechanism involved in cough 
production. Evidence has shown that a single network of neurons seems to mediate cough 
as well as breathing (Shannon et al., 1996; Shannon et al., 1997; Shannon et al., 1998; Shannon et 
al., 2000). 
Though, it is obvious that cough and breathing are two different behaviors. It is a process 
called reconfiguration, in which the same network produces different behaviors that 
involve dynamic alteration of the excitability of key elements and/or recruitment of 
previously silent elements. There is suggested that the excitability of this network is 
additionally controlled by a ´gating´ mechanism that is sensitive to antitussive drugs 
(Bolser et al., 1999).  
2.3 Plasticity 
Coughing is connected with both acute and chronic respiratory diseases such as upper 
respiratory infections, asthma, gastro-oesophageal reflux (GOR), as well as other more 
seldom causes. It is likely that the cough arises due to production of various tussigenic 
agents in the wall of the airway, and increased sensitivity of the cough reflex pathway. 
Though, the structures involved and the molecular mechanism of the sensitivity is still 
unknown. Afferent nerves are under constantly changing in structure and activity. 
Neuroplasticity is the general term to the change in structure and function of nerves (Woolf 
& Salter, 2000). Cough plasticity represents the changes in neuronal excitability, receptor 
expression, transmitter chemistry and the structure of the nerve. Unfortunately, not much is 
known about the function of vagal nerve plasticity in human disease. Most facts have been 
collected by using various tissue and animal models in studies on the somatosensory 
system, and functional and electrophysiological studies of the vagal afferent nerves.  
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Clinical studies on cough reflex sensitivity show that it can be quantified by several methods 
(Pounsford et al., 1985a; Choudry & Fuller, 1992). Capsaicin and citric acid are the most 
commonly used tussigenic agent, and their use have expressed that some diseases are 
associated with an appreciable increase in cough reflex sensitivity. During these studies one 
must take into consideration that cough reflex hypersensitity may be stimulus specific, and 
thereby influence the cough sensitivity.  
2.3.1 Molecular mechanisms of increased excitability 
Allergic inflammation or various inflammatory mediators have under scientific level shown 
to both increase cough reflex sensitivity and excitability of afferent nerves of the airway. For 
example, in humans PGE2 enhance capsaicin-induced cough (Choudry et al., 1989). It has also 
been done a large amount of clinical studies that have displayed that certain pathological 
conditions are accompanied by a considerable increase in cough reflex sensitivity in 
humans. This is also shown in studies done on animals, for example in guinea-pigs, when 
allergic inflammation or inhalation of bradykinin potentiated cough was evoked by 
capsaicin and citric acid (Lii et al., 2001). Studies done in rats have shown that inhalation of 
inflammatory mediators (also PGE2 and eosinophil major basic protein) follow potentiation 
of capsaicin-induced action potential discharge in nociceptive fibers in the lungs (Ho et al., 
2000). In addition, inflammatory condition enhances the excitability of RARs fibers. As in 
studies on sensitized guinea pigs trachea was exposed to antigen causing a substantial 
increase in the mechanosensitivity of RARs fibers (Riccio et al., 1996a). Later, it has been 
shown that cough may be evoked in all species used in studies by using either chemical 
stimulation of airway mucosa or by inhalation of acidic saline or capsaicin (Canning, 2008). 
Besides these studies done, relatively little studies resulting in published articles have 
occurred relating to the airway afferent excitability and the underlying mechanisms that 
increases it. 
Most of the studies on mechanistic basis of afferent nerve excitability and plasticity have 
been done on nociceptive-type somatosensory neurons which are isolated from the dorsal 
root ganglia (Woolf & Salter, 2000). Somatosensory- and airways nociceptive fibers share 
many properties and therefore give useful information on how the excitability on the airway 
nociceptor works. But, one must not exclude the fact that RARs phenotype fibre is not 
readily analogous to any type of somatosensory afferent. So, still little is known in how the 
airway RARs excitability is modulated. 
2.3.2 Vanilloid receptor (TRPV1) mechanisms 
Vanilloid receptor now referred to as TRPV1 (previously called vanilloid receptor 1 (VR1)), 
is of the vagal afferent nociceptors (C-fibers and Aδ-fibers) that innervate the airway express 
the capsaicin receptor, a member of the transient potential family (Riccio et al., 1996b; Fox, 
2002). Unfortunately, the extent to which capsaicin can lead to RARs activation in vivo is 
likely trough indirect means because TRPV1 is not expressed by RAR-type fibers in the 
airways of guinea-pigs (Myers et al., 2002). 
Membrane depolarization is a result of the TRPV1 which work as an ionotropic receptor that 
when activated serve as a nonselective cation channel leading to depolarization of 
membrane (Caterina & Julius, 2001). It is important to know that besides being activated by 
vanilloid compounds, TRPV1 is also activated by endogenous lipid mediators such as 
ananamide and arachidonic acid metabolites of various lipoxygenase enzymes (Caterina & 
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Julius, 2001; Shin et al., 2002). Some metabotrophic receptors of TRPV1 may also be activated 
by intracellular signal transduction mechanism. Studies in both airway afferent fibers and 
somatosensory neurons indicate the hypothesis that bradykinin can, at least partly, activate 
sensory nerves through production of lipogenase product of arachidonic acid and 
subsequent activation of TRPV1 (Shin et al., 2002). One other important fact is the hydrogen 
ions ability to activate TRPV1 on airway physiology with pH ~6 at 37°C (Caterina & Julius, 
2001). 
TRPV1 also have a distinct characteristic by its ability to integrate different kinds of stimuli, 
meaning that the action of one TRPV1 agonist potentiates the action of the other (Caterina & 
Julius, 2001). TRPV1 have the ability to accumulate in the airway wall during different kinds 
of pathological condition. As in asthma, the inflammation could, by a decrease of pH of 
airway wall, increase the concentration of hydrogen ions, bradykinin and certain lipid 
mediators. 
Increase of TRPV1 conductance secondary to phosholipase C (PLC) activation and 
subsequent phosphorylation of TRPV1 by protein kinase C (PKC) can be done by agonists of 
protein G protein-coupled (Gp-coupled) receptors (Premkumar & Ahern, 2000). This indicates 
that inflammatory mediators that stimulate classical G-protein-coupled receptors can 
increase conductance through TRPV1. There are evidence showing that PLC may also 
release TRPV1 from phosphatidylinositol (Riccio et al., 1996b) and phosphate inhibition 
(Chuang et al., 2001). This action may take part in increasing the TRPV1 activity after 
stimulation of nerve growth factor (NFG) of Tyrosine Receptor Kinase A (trk-A) receptors as 
well as B2-receptors activation by bradykinin. 
Gs-coupled receptors may also increase the amplitude of the TRPV1-mediated generator 
potential. In rats, rising of cAMP increases capsaicin-induced conductance in their 
nociceptive neurons, an action that may be inhibited by protein kinase A (PKA)-inhibitors 
(Lopshire & Nocol, 1998). Further studies also show that in rat pulmonary nociceptors 
capsaicin-induced action potential discharge is increased by prostaglandin E2 (PGE2 ) (Ho et 
al., 2000). It is also proven that there is an increase in expression of TRPV1 in rat sensory 
neurons by neutrophins like NGF (Michael & Priestley, 1999). Even though it is not made any 
studies in humans concerning healthy or diseased airways, places of airway inflammation is 
known to be elevated by nerve growth factors (Virchow et al., 1998). TRPV1 is not the only 
mechanism that can affect nociceptor excitability. Decrease of threshold for mechanical 
stimulation of airway afferent nerves have been shown in various inflammatory mediators 
(Ho et al., 2000; Riccio et al., 1996a). How this is done is still unknown, but studies suggest 
that it might involve several ion channels and modulation of these. 
2.3.3 Sodium channels 
Voltage-gated sodium channels have the possibility to affect the threshold for action 
potential generation and peak frequency of action potential discharge both in number and 
activity. The mammals have abundant of different sodium channels in nerves, and based on 
their sensitivity to tetrodotoxin (TTE) we divide them into two groups, the TTX-sensitive 
and TTX-resistant sodium channels. In airway afferent nerves both groups of channels are 
found (Carr & Undem, 2001). Of extra interest are the TTX-resistant channel and its ability to 
regulate excitability of modulation by inflammatory mediators (Gold et al., 1996). Studies 
made on guinea-pigs and their jugular ganglia showed that most of these nerves have 
enough TTX-resistant sodium channels to achieve an action potential generation (Christian & 
www.intechopen.com
 
Allergic Rhinitis 
 
88
Togo, 1995). Even though there still are some questions about the details of the channels 
function, there are data proving that airway-specific jugular neuronal cell bodies have 
enough TTX-resistant current to support formation of action potential (Carr & Undem, 2001). 
Some inflammatory mediators have influence the sodium current. PGE2, adenosine and 5-
hydroxytryptamine (5-HT) are some mediators that have shown to be able to enhance the 
TTX-resistant sodium current in somatosensory neurons (Gold et al., 1996). Though, what 
impact these mediators have are still not established. 
2.3.4 Neurotransmitter plasticity 
Neuropeptides are present both in peripheral and central C-fibers innervating the airways, 
and substance P and related tachykinins are the most common neuropeptides, though other 
peptide are also found there. 
An increased production of different types of neuropeptides in inflammatory disease is a 
typical action, and is proven in animal models and several inflammatory diseases, such as 
COPD (Tomaki et al., 1995). This action often happens after an increase in expression of 
preprotachykinin genes in the sensory neurons (Hunter et al., 1998; Fischer et al., 1996). How 
the signalling occurs is still not known, but neutrotrophins are believed to be involved since 
they are known to interact with tyrosine kinase-linked receptors (trk receptors) to evoke 
signals in the cell body. Neurotrophin–trk receptor complexes affect transcriptions of 
different genes, also those involving neuropeptide synthesis and are likely transported via 
axonal system from nerve terminals to the cell body (Klesse and Parada, 1999). In the presence 
of airway inflammation, neurotrophins such as nerve growth factor (NGF) and brain-
derived neurotrophin factor are rarely found, and production may even be increased 
(Virchow et al., 1998). 
In inflammatory reactions release of neurokinins may cause vasodilatation, plasma 
extravasation, and even bronchial smooth cell contraction in some species (Advenier & 
Emonds-Alt, 1996). These actions have shown in indirectly activate RARs nerves in guinea-
pigs which further participate in tussigenive activity of these agents (Advenier & Emonds-Alt, 
1996; Joad et al., 1997). Neuropeptides are synthesized in body cells, transported to 
peripheral and central terminals and in central terminals in brainstem they are released after 
action potential release (Woolf and Salter, 2000). This release in the central terminals is likely 
to have an essential role in regulating the cough reflex sensitivity. RARs fibers in central 
neurons have shown in some cases to have a convergence on the same secondary terminals 
as nociceptive C-fibers (Mazzone & Canning, 2002). This evidence, and adding the fact those 
electrophysiological effects on neurokinins on postsynaptic membrane provide the abstract 
model of the process that is called by scientists ”central sensitization”(Woolf & Salter, 2000). 
This refers to the action where one type of nerve input, for example nociceptive C-fibre, 
actually increases the synaptic transmission of another type of input, as in RARs fibers. This 
may lead to a decrease in the amount of RAR input needed to trigger cough in the CNS.  
While older studies suggest that inflammation may cause increase in sensory neuropeptides 
secondary to induction of preprotachykinin genes in nociceptive neurones, it is now 
indicated in studies of both somatosensory and vagal sensory systems, that inflammation 
also may cause phenotypic change in the neuropeptidergic innervation (Neumann et al., 
1996; Carr et al., 2002; Myers et al., 2002). Studies of airway afferent neurones in guinea pigs 
with allergen or virus infection showed increased number of sensory neurokinins (Fischer et 
al., 1996; Carr et al., 2002; Myers et al., 2002). In response to inflammation there is also 
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histologically proved that the neuropeptides produced in this case are also transported to 
central terminals of the RAR neurons (Myers et al., 2002). This is an important finding which 
supports the fact that there is a mechanical activation of RARs fibers leading neurokinin 
release in the brainstem as a response to inflammation from allergy or respiratory virus 
infection. A neuropeptide innervation of the somatosensory system has been documented 
where painful sensation has phenotypically shifted to painless stimuli, an action referred to 
as allodynia (Neumann et al., 1996). From this one could start to wonder if this may have 
some influence in the extraneous cough sensation that may cause the desire to cough 
without having any to cough up in the airway. 
2.3.5 Change in nerve fibre density and extraneuronal effects 
The environment causes change in the density of sensory innervation (Stead, 1992). This 
change due to either growth factor release or tissue damage may lead to nerve fibre growth 
and fibresprouting, but if this causes an increased sensitivity to cough is still unknown and 
minimal studies have been done on this topic. 
3. Cough in adults 
European Respiratory Society recommends two possible definitions of cough (Morice et al., 
2007): 1) Cough is a three-phase expulsive motor act characterized by an inspiratory effort 
(inspiratory phase), followed by a forced expiratory effort against a closed glottis 
(compressive phase) and then by opening of the glottis and rapid expiratory airflow 
(expulsive phase). 2) Cough is a forced expulsive maneuver, usually against a closed glottis 
and which is associated with a characteristic sound. 
Cough is classified as acute and chronic. This classification is useful clinically, since the 
etiology of acute cough differs from the etiology of chronic cough. Chronic cough in adults 
is a cough which persists for over 8 weeks. 
3.1 Acute cough in adults 
Cough is the commonest symptom for which people seek medical advice (Irwin et al., 1993). 
Lower airway infections are the most common cause of acute cough. Lower airway 
infections refer to acute tracheobronchitis, acute bronchiolitis and community acquired 
pneumonia (CAP). Acute tracheobronchitis is mostly viral in origin. Influenza virus, 
rhinovirus, parainfluenza virus, Respiratory syncytical virus (RSV), adenovirus and 
coronavirus are the pathogens most commonly associated with acute cough in patients with 
acute tracheobronchitis. All these viruses have a short incubation period of between one and 
four days, and all symptoms including cough usually resolves within three weeks (Pek & 
Boushey, 2003). Many people with viral cough do not seek medical advice, but treat 
themselves with over the counter products. This means that there is no sufficient statistical 
data about the extent of acute cough (Morice, 2003). 5-10% of all cases with acute 
tracheobronchitis are caused by bacteria. Among the most common bacterial pathogens are 
Bordetella pertussis, Mycoplasma pneumoniae, Streptococcus pneumoniae and Chlamydia 
pneumoniae. CAP is a common cause of hospitalization and death from infectious disease in 
adults. The etiological agent is identified in only 50% of all cases. Streptococcus 
pneumoniae, Haemophilus influenzae and Staphylococcus aureus are among the most 
commonly identified microbial pathogens that cause pneumonia (Pek & Boushey, 2003). 
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The mechanism of cough in lower airway infection is not completely understood. Possible 
mechanisms have been suggested by Pek & Boushey (2003): 1) Irritation of the nerve endings 
in the larynx and trachea caused by dripping of secretions containing inflammatory 
mediators from the nasopharynx into larynx or trachea is one possible mechanism. 
Exposure of the nerve endings (e.g. RARs) caused by damage and destruction of the airway 
epithelium is thought to decrease the cough threshold to environmental irritants and 
inflammatory secretions, thus causing cough. 2) The infection of the airways also leads to 
accumulation of secretions and debris in the airway lumen. As a result the 
mechanoreceptors in the bronchial mucosa are activated, triggering cough to clear the 
airways for the excess secretions and foreign material. 3) Cough may also occur because of 
stimulation of nerve endings by inflammatory mediators released directly from airway 
epithelial cells or from inflammatory cells attracted to the site of infection. 4) 
Neuropeptidases degrade neuropeptides released from adjacent afferent nerve endings. 
Enhanced effect of neuropeptidases because of decrease in the neutral endopeptidase from 
epithelial cells is also one possible mechanism triggering cough in lower airway infections. 
3.2 Chronic cough in adults 
The three most common causes of chronic cough are asthma bronchiale, GERD and chronic 
upper airway syndrome (CUAS) – previously postnasal drip syndrome. Other causes of 
chronic cough include post viral cough, cough in patients with chronic obstructive 
pulmonary diseases, cough induced by ACE inhibitor therapy and cough in lung cancer 
patients (Chung et al., 2003). 
A single cause of cough in a patient is less common than multiple causes of cough. In a 
study performed by Palombini et al. (1999) they found that asthma, CUAS, GERD either 
alone or in combination, were responsible for 93.6% of the cases of chronic cough. These 
three conditions were so frequent that they suggested the use of the term “pathogenic triad 
of chronic cough”. 38.5% of the patients investigated had a single cause of cough, while 61.5 
% of the patients had two or more causes of cough. 
3.3 Acute cough in children 
Some studies of acute cough are old and show systematic reviews on the natural history of 
the acute cough in children (35-50years). Hay and Wilson (2002) did prospective study of 
the period 1999-2001 of acute cough, which displayed that within 10 days 50% of the 
children showed recovery, and 90% within 25 days. Also an Australian prospective 
community study recorded respiratory episodes of 2.2-5.3 year for children aged ≤ 10 years, 
with results showing a mean duration of 5.5-6.8 days of the episodes (Leder et al., 2003). 
Thereby indicating that acute cough should be defined as cough less then 14 days of 
duration. 
The most common etiology of acute cough in children is due to an uncomplicated viral acute 
respiratory tract infection, though one must exclude more serious problems as aspiration of 
foreign material (Chang et al., 2006). 
3.4 Chronic cough in children 
Acute cough in childrenis defined as cough less than 2 weeks, prolonged acute cough 
(subacute) 2-4 weeks, chronic cough more than 4 weeks (Chang et al., 2006). Definition of 
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cough in adults is subdivided differently. Acute cough duration is of less than 3 weeks, 
subacute 3-8 weeks and chronic more than 8 weeks (Pratter el al., 2006; Morice et al., 2007). 
Chronic cough may be classified according to its etiology. By this classification cough is 
divided into ´expected´ cough, non-specific cough and specific cough; its scientific rationale 
is discussed elsewhere (Chang, 2005). In expected cough, the cough is anticipated, such as 
after an acute respiratory tract infection. In specific cough the cause is clearly definable by 
usage of history and examination, where coexisting symptoms and sign often help in 
diagnosing the etiology. These causes are often serious. Nonspecific cough is a dry cough 
where neither known aetiology nor any respiratory disease has been identified. Chronic 
cough in children is most commonly due to an upper respiratory tract infection, asthma, 
gastrointestinal reflux as well as other more uncommon causes. 
3.5 Cough reflex sensitivity assessment 
The cough reflex sensitivity can be assessed by the inhalation cough challenge test. In this 
test an acid or a non-acid tussive is used to induce cough experimentally. The most common 
non-acid tussive is capsaicin, while citric and tartaric acids are the most commonly used 
acid tussives. Before 2007 standardized methods did not exist, making it impossible to 
compare data in studies obtained from different institutions. The European Respiratory 
Society (ERS) developed guidelines in 2007 on the standardization of testing with tussive 
and non tussive tussives (Morice et al., 2007). 
During the inhalation cough challenge test, the tussives can be administered either by using 
single-dose or the dose-response method (Morice et al., 2001). In the single-dose method, one 
concentration of capsaicin or citric acid is administered. In the dose-response method the 
tussives are administered over a prolonged period. In the dose-response method, variations 
in respiratory frequency and tidal volume are thought to cause variation in the amount of 
tussive delivered from individual to individual, and therefore accuracy and reproducibility 
is poor. The single dose method is the most widely used method, because of the accuracy 
and reproducibility of the dose delivered (Morice et al., 2007). 
The inspiratory flow rate affects the pattern of distribution of the tussives in the airways. 
Variation in the inspiratory flow rate thus will affect the cough challenge test. The lowering 
the inspiratory flow rate will increase the cough response to citric acid. Controlling the flow 
rate ensures that the same amount of tussive is delivered to different individuals (Barros et 
al., 1991). To control the inspiratory flow rate, ERS currently recommend the use a 
compressed air-driven nebulizer controlled by a dosimeter modified by an inspiratory 
regulatory flow regulator valve (Morice et al., 2007). 
The patient should be told not to suppress any coughs and not to talk immediately after 
inhalation of the tussive, since talking suppresses the cough response. The cough induced 
by capsaicin and citric acid occur immediately and only sustain for a short period. Therefore 
only coughs that occur within 15 sec after the administration of the tussive should be 
counted. Any cough occurring after this interval should not be counted, since it is not likely 
to be induced by the tussive agent. In studies the concentration of the selected tussive agent 
causing two (C2) and five (C5) coughs are reported. C2 is the concentration first resulting in 
2 or more coughs, while C5 is the first concentration resulting in 5 or more coughs. In 
patient with high cough threshold a C5 value may not be possible to obtain, and ERS 
recommend that these individuals are excluded from the clinical trials (Morice et al., 2007). 
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During the cough challenge test it is also recommended to use placebo inhalations with 
physiological saline (Morice et al., 2001). The saline solution should be used randomly 
between the different concentrations of the tussive agent. This is thought to decrease 
voluntary suppression of cough (Morice et al., 2007). 
Tachyphylaxis is the process in which the effect of a drug is reduced during continuous use 
or by constantly repeated drug administration. In one study that used continuous inhalation 
over 1 min with capsaicin, the cough frequency was reduced by one third. In continuous 
inhalation with citric acid, no coughs were evoked after the 1 min period (Morice et al., 1992). 
The ERS recommends an interval between cough challenge measurements of minimally 1 
hour. The optimal interval is set by the ERS to 2 hours. 
No serious adverse effect is associated with cough challenge testing using capsacin as 
tussive agent. The most commonly reported side effect is transient throat irritation (Morice et 
al., 2007). 
Citric acid inhalation may result in a small reduction of forced expiratory volume (FEV), but 
this is thought to be without clinical significance (Laude et al., 1993). Capsaicin induces 
bonchoconstriction, but it is not tough to have clinical significance in healthy individuals or 
in individuals with asthma bronchiale. However, ERS recommend that bronchodilators 
should be easily available when a cough challenge test is performed (Morice et al., 2007). 
4. Cough in rhinosinusitis 
Rhinitis refers to inflammation of the nasal mucosa, while sinusitis means inflammation of 
the mucosa in one or more of the paranasal sinuses. A continuum exists between rhinitis 
and sinusitis owing to the anatomical and physiological relationship of the nose and 
paranasal sinuses. Sinus inflammation generally develops in association with rhinitis and 
the term rhinosinusitis is applied to these disorders (Probst et al., 2005). Chronic 
rhinosinusitis is among the commonest causes of chronic cough in adults. In 20-40% of 
patients with chronic cough who have normal chest x-ray, chronic rhinosinusitis is reported 
to be the cause of the cough (Tatar et al., 2009). 
Chronic rhinosinusitis may be caused by diseases of a chronic inflammatory, allergic, 
traumatic or neoplastic nature. Chronic rhinosinusitis may also develop as a result of 
anatomical changes, as seen in e.g. septal deviation or septal spurs. Impaired ventilation of 
the ostiomeatal unit caused by obstruction or stenosis is the common mechanism for 
development of rhinosinusistis. The obstruction impairs drainage from the sinus systems. 
The drainage is further impaired by swelling of the mucosa in the narrow anatomical canal 
of the ostiomeatal unit. A viscous circle of recurrent acute inflammations that develops into 
a chronic inflammation is established. In adults the maxillary and ethmoid cells are the 
sinuses most commonly affected (Probst et al., 2005). 
The mechanism of chronic cough in rhinosinusitis is until now not completely understood. 
Chronic upper cough syndrome, previously postnasal drip, cough reflex hypersensitivity 
and aspiration of secretions are among the mechanisms thought to be responsible, either 
alone or in combination (Tatar et al., 2009). 
The cough is produced by stimulation of the pharyngeal nerve endings, which are branches 
of the vagus nerve. The stimulation occur secondary to secretion from the nose and sinuses 
dripping into the hypopharynx, a process known as postnasal drip (Palombini & Araujo, 
2003). However, only some of the patients with postnasal drip complain of cough, and some 
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patients with chronic cough caused by rhinosinusitis do not experience postnasal drip. 
Therefore it is unlikely that postnasal drip is the only mechanism responsible for cough in 
nasal disease (Tatar et al., 2009). Cough reflex sensitization is often observed in patients with 
chronic cough, including those with nasal diseases. The cough reflex cannot be triggered 
from the nose, but cough reflex sensitization may occur in nasal diseases. Tatar et al. (2009) 
have suggested that central sensitization of the cough reflex mediated by the nasal 
trigeminal sensory nerves may be one of the possible mechanisms of chronic cough in 
patients with nasal diseases. Chronic cough in nasal diseases may also be secondary to 
aspiration of secretions. The secretions are thought to stimulate the vagal afferents in the 
lung, thereby mediating cough. However more evidence is needed before this last 
mentioned mechanism can be accepted as a mechanism of cough in nasal diseases (Pratter, 
2006). 
The diseases of the nose and paranasal sinuses are among the most commonly identified 
causes of chronic cough (Pratter, 2006). Depending on the population studied and the 
variations in diagnostic algorithm, the diseases of nose and sinuses are reported to 
contribute to coughing in 20–40% of patients with chronic cough who have normal chest 
radiograph (Chung & Pavord, 2008). The mechanisms of chronic cough in rhinosinusitis are 
incompletely understood. Several mechanisms have been proposed, single or in 
combination: postnasal drip (PND), direct irritation, inflammation in the lower airways and 
the cough reflex sensitization (Pratter, 2006).  
4.1 Cough reflex hypersensitivity 
Cough reflex hypersensitivity refers to a condition in which the cough reflex is more readily 
inducible. Cough reflex hypersensitivity can be demonstrated as 1) the lowered intensity of 
a stimulus required to trigger cough or 2) enhanced coughing in response to a stimulus with 
the constant intensity. In clinical and laboratory experiments, the cough reflex 
hypersensitivity is detected by measuring the cough threshold or by evaluating changes in 
the number of coughs induced by a stimulus with defined intensity. The cough threshold is 
measured by a controlled inhalation of increasing concentrations of an aerosolized tussigen, 
commonly capsaicin or acidic solutions (Morice et al., 1997) and (Choudry & Fuller, 1992). The 
cough threshold is defined as the lowest concentration of the tussigen required to induce a 
predetermined number of coughs (typically 2 and 5 coughs, denoted C2 and C5, 
respectively). The cough reflex hypersensitivity is found when the cough threshold in the 
patient group is lower than in the appropriate reference group. 
The cough reflex hypersensitivity is often reported in patients with chronic cough attributed 
to disparate causes including nasal diseases (McGarvey et al., 1998). It is implied that the 
cough reflex hypersensitivity contributes to coughing. In patients with a sensitized cough 
reflex, the environmental and endogenous stimuli are predicted to be more effective to 
trigger cough. Thus the cough reflex hypersensitivity results in the amplification of cough, 
similar to the amplification of pain in hyperalgesia. The observations that the cough 
sensitivity decreases with the successful treatment or natural resolution of cough also 
support the notion that the cough sensitization contributes to coughing (McGarvey et al., 
1998, O´Connell et al., 1994, O´Connell et al., 1996). 
There is a consensus that the cough reflex cannot be triggered from the nose. There is the 
mechanistic question whether the cough reflex can be sensitized from the nose. Based on the 
general concept that the activation of nasal sensory nerves leads to cough reflex 
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hypersensitivity, a series of studies in humans and in animal models were carried out (Tatar 
et al., 2009). 
4.2 Sensory nerve activators in the nose sensitize the cough reflex 
The hypothesis that the afferent nerve activators applied into the nose sensitize the cough 
reflex in humans by using sensory activators histamine and capsaicin was aevaluated. 
Histamine is a prototypic mediator of nasal inflammation that directly stimulates a subset of 
nasal sensory nerves (Taylor-Clark et al., 2005). The TRPV1 selective agonist capsaicin is also 
an efficient activator of the nasal sensory nerves (Taylor-Clark et al., 2005). A large proportion 
of the TRPV1-positive trigeminal neurons innervating the nose express a variety of receptors 
relevant for detection of stimuli associated with inflammation. For example, nasal trigeminal 
neurons functionally express the histamine H1 receptor, the leukotriene cys-LT1 receptor 
(Taylor-Clark et al., 2005; Taylor-Clark et al., 2008a, Taylor-Clark et al., 2008b). Intranasal 
administration of capsaicin likely stimulates large proportion of nerves that are also 
stimulated or modulated by nasal inflammation. Local and reflex consequences of the 
sensory nerves activation with histamine and capsaicin (such as substance P release from 
peripheral terminals and reflex vasodilation) may generate additional stimuli that further 
stimulate nasal sensory nerves (Tani et al., 1990; Petersson et al., 1989). In addition, direct 
effects of histamine on the cells other than sensory nerves likely lead to generation of more 
endogenous sensory stimuli. 
Consistent with the extensive data from human studies (Philip et al., 1994; Secher et al., 1982) 
intranasal administration of histamine and capsaicin failed to trigger cough in healthy 
subjects (Plevkova et al., 2004; Plevkova et al., 2006). The effective activation of nasal sensory 
nerves by histamine and capsaicin was confirmed by the occurrence of sensations and 
symptoms typically described after intranasal administration of these agents. The cough 
was induced by inhalation of a tussigen aerosol during the time window of the most 
pronounced nasal symptoms evaluated by a composite score. 
Both histamine and capsaicin applied into the nose caused sensitization of the cough reflex 
in healthy subjects (Plevkova et al., 2004; Plevkova et al., 2006). Following the intranasal 
administration of capsaicin or histamine, the number of coughs induced by inhalation of a 
defined dose of capsaicin was increased by 60–80%. Similarly, intranasal histamine did not 
trigger cough but sensitized the cough reflex in patients with allergic rhinitis (Plevkova et al., 
2005). These data are consistent with the hypothesis that the activation of nasal sensory 
nerves sensitizes the cough reflex (Tatar et al., 2009). 
4.3 Cough reflex is sensitized in patients with allergic rhinitis 
The cough reflex hypersensitivity in patients with allergic rhinitis was evaluated (Pecova et 
al., 2005; Pecova et al., 2008). Chronic nasal symptoms attributable to sensory nerve activation 
in patients with rhinitis implicate that the inflammation leads to repeated activation of 
sensory nerves. The repeated activation and mediators associated with inflammation can 
induce sensitization at multiple levels of sensory pathways. Thus we predicted that the 
cough reflex is more sensitive in patients with allergic rhinitis than in healthy subjects 
(Pecova et al., 2005; Pecova et al., 2008, Tatar et al., 2009). 
The grass pollen-sensitive patients with allergic rhinitis were studied out of pollen season. 
All patients included in the studies were free of nasal symptoms at the time of investigation. 
We found that the cough reflex was more sensitive in patients with allergic rhinitis 
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compared to healthy subjects (measured by the capsaicin C2 cough threshold) (Pecova et al., 
2005). This finding was reproduced in a separate study in which the capsaicin C5 threshold 
was evaluated in another groups of patients and healthy subjects (Pecova et al., 2008). In this 
study, the concentrations of capsaicin causing five coughs (C5, geometric mean and 95% CI) 
were 132.4 (41.3–424.5) μM and 13.1 (6.0–28.6) μM in healthy subjects (5 M/7F, mean age 23 
yrs) and patients with allergic rhinitis (5 M/7F, mean age 23 yrs), respectively (P < 0.05). We 
conclude that the cough reflex is sensitized in patients with allergic rhinitis (Pecova et al., 
2008). 
Since the symptoms of allergic rhinitis in pollen-sensitive patients are most prominent 
during the pollen season, we hypothesized that the sensitization of cough is most 
pronounced in this period. Fifteen patients were evaluated out of pollen season (January–
February) and in the grass pollen season (May–June) in a paired study(Pecova et al., 2005). 
The capsaicin cough C2 threshold was reduced in the pollen season vs. out of the pollen 
season, 0.11(0.3–0.33) μM vs. 0.84(0.14–5.2) μM, respectively (P < 0.05). Thus the cough reflex 
in patients with allergic rhinitis is further sensitized in the period when the nasal 
inflammation is more active. 
4.4 Sensitized cough reflex and coughing in humans 
In a series of studies it was demonstrated that the cough reflex in healthy subjects is 
sensitized by the intranasal administration of sensory nerve activators (Plevkova et al., 2004; 
Plevkova et al., 2006). These results are consistent with the hypothesis that the activation of 
nasal sensory nerves sensitizes the cough reflex (Tatar et al., 2009). We also show that the 
cough reflex is sensitized in patients with allergic rhinitis Pecova et al., 2005; Pecova et al., 
2008, Tatar et al., 2009) and is further sensitized in this group by intranasal sensory activator 
histamine (Plevkova et al., 2005) and during the period of more active nasal inflammation 
(Pecova et al., 2005). Our results may help to explain the mechanisms contributing to chronic 
cough associated with rhinosinusitis (Tatar et al., 2009). 
These results are highly indicative that nasal sensory nerves are the neural pathways 
involved in the sensitization of cough. The wealth of data from the somatosensory (Jiand & 
Woolf, 2001) and vagal (Mazzone et al., 2005; Mazzone & Canning, 2002) systems allows for an 
informed speculation that central cough reflex hypersensitivity mediated by nasal sensory 
nerves underlies the observed cough sensitization. In this scenario the afferent inputs from 
the nose feed into the central regulatory circuits of the cough reflex in a manner rendering 
the cough reflex hypersensitive. It has been demonstrated that the cough reflex triggered 
from trachea is sensitized by the stimulation of sensory nerves innervating distal parts of the 
respiratory system (lungs) in animal models (Mazzone and Canning, 2005), or even from the 
esophagus in humans (Javorkova et al., 2008). The sensitization of cough by the nasal 
trigeminal sensory pathways is perhaps more complex than the vagally mediated 
sensitization, since the trigeminal and the cough-triggering vagal sensory nerves terminate 
in different areas of the brainstem. Interestingly, the sensitization of cough from the nose 
can be induced even in anaesthetized animals, suggesting that the cough sensitization does 
not require intact cortical function. 
The situation is more complex in patients with allergic rhinitis. Our data discussed thus far 
predict that the cough reflex hypersensitivity mediated by acute sensory nerve activation 
occurs in the symptomatic patients. However, in the patients without symptoms (such as the 
patients with allergic rhinitis out of the allergen season) the absence of the symptoms 
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indicates limited nasal sensory activity. Yet the cough reflex is strongly sensitized in this 
group (Pecova et al., 2005; Pecova et al., 2008, Tatar et al., 2009). It seems unlikely that the nasal 
sensory nerves in patients without symptoms are stimulated in a manner that is sufficient to 
maintain the cough sensitization but insufficient to trigger the symptoms. Rather, we 
speculate that the cough sensitization is induced by sensory activation during the period 
with symptoms and then outlasts the sensory activation. Inflammatory mediators, 
neurotrophic factors and other signals emanating from the nose during symptomatic period 
could, in theory, initiate long-lasting neural plastic changes in the circuits regulating the 
cough reflex (Chen et al., 2001; Bonham et al., 2006). Mechanistic studies are needed to 
evaluate this speculation. 
Nasal provocation with histamine induces significantly stronger sneezing responses in 
subjects with allergic rhinitis compared with healthy subjects – a sensitized sneezing reflex 
(Gerth Van Wijk & Dieges, 1987; Sanico et al., 1999). We noted that intranasal histamine was 
more effective in reducing the capsaicin cough threshold in patients with allergic rhinitis 
than in healthy subjects (Plevkova et al., 2004; Plevkova et al., 2005). The simplest explanation 
is that the nasal sensory nerve pathways are sensitized, resulting in increased sensory 
feeding into the cough and sneeze regulatory areas. It is noteworthy in this context that 
nasal inflammation induces lasting changes in expression of molecules predicted to 
positively regulating activation and excitability in nasal afferent nerves (O´Hanlon et al., 
2007; Keh et al., 2008). However, a separate sensitization of cough and sneezing at the higher 
regulatory levels of cough and sneezing reflexes is also a viable option. 
Another explanation is that the cough reflex is sensitized in patients with allergic rhinitis 
because of allergic inflammation in the lower airways and lungs. This possibility cannot be 
excluded. Numerous studies have shown that the inflammation in the lower airways and 
lungs in patients with allergic rhinitis is in many aspects similar to that in asthmatics 
(exemplified by Braunstahl et al., 2003). However, the studies in asthmatics failed to 
consistently show lowered capsaicin or citric acid cough thresholds (Fujimura et al., 1992; 
Chang et al., 1997; Schmidt et al., 1997). Since this is in contrast with the dramatic sensitization 
of cough in allergic rhinitis, this mechanism likely plays only a limited role. 
Allergic rhinitis was chosen as a model of a well-defined nasal inflammation allowing for 
selection of a relatively homogeneous patient population (skin prick test pollen-sensitive 
patients). Although the cough reflex was sensitized in allergic rhinitis, none of the patients 
complained about coughing. The increased cough reflex sensitivity is consistently found in 
patients with chronic cough and the effective treatment of cough is accompanied by 
normalization of the cough hypersensitivity. These observations advanced the hypothesis 
that the cough reflex hypersensitivity is the mechanism causing the cough. However, the 
cough reflex hypersensitivity has been also reported in other groups of patients who do not 
suffer from chronic cough. For example, the cough reflex sensitivity to capsaicin is increased 
in the GERD patients who do not complain about cough (Benini et al., 2000; Ferrari et al., 
2005). Interestingly, the magnitude of the cough threshold reduction in the GERD patients is 
comparable to that found in chronic coughers, and the cough threshold reduction in allergic 
rhinitis appears to be even larger. The cough hypersensitivity without cough was also found 
in other diseases (Pecova et al., 2003a; Pecova et al., 2003b). 
The observations that the cough reflex hypersensitivity is not always accompanied by cough 
force the conclusion that the cough reflex hypersensitivity alone is not sufficient for clinical 
presentation of chronic cough. Rather, the increased cough reflex sensitivity contributes to 
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chronic cough by amplifying the cough triggered by endogenous and, perhaps less likely, 
environmental stimuli. While the cough reflex sensitivity is predicted to worsen the cough, 
it is unlikely to be its only causal mechanism (Tatar et al., 2009). 
4.5 Potential mechanisms triggering cough in patients with rhinosinusitis and cough 
The cough reflex hypersensitivity is predicted to amplify cough by increasing the efficiency 
of endogenous and environmental stimuli to trigger cough but is unlikely to cause chronic 
coughing by itself. There is an ongoing discussion in the literature whether diseases of the 
nose actually trigger cough (Morice, 2004; Sanu & Eccles, 2008). This confusion is also 
reflected in the recommendation of the term upper airway cough syndrome (UACS) to be 
used when discussing cough that is associated with upper airway conditions (Pratter, 2006). 
One proposed mechanism for triggering cough in rhinosinusitis is the postnasal drip 
(drainage of secretions from the nose or paranasal sinuses into the pharynx). In this scenario 
the cough-triggering nerves located in the hypopharynx or larynx are stimulated by 
secretions emanating from the nose and/or sinuses dripping down into these areas (Irwin et 
al., 1984). The arguments against postnasal drip as a sole cause of cough in rhinosinusitis are 
twofold. Postnasal drip is a common phenomenon, and only a small fraction of patients 
with the postnasal drip also complain about cough (O´Hara & Jones, 2006). Conversely, a 
proportion (reported ~20%) of patients with chronic cough attributed to rhinosinusitis do 
not experience postnasal drip. It seems therefore unlikely that postnasal drip is the exclusive 
mechanism triggering cough. Cough in rhinosinusitis could be also conceivably triggered by 
aspirated secretions stimulating cough receptors in the lower respiratory tract; however, 
there are limited data to support this mechanism (Pratter, 2006). As is the case with 
postnasal drip, the aspiration or inhalation of nasal secretions likely occurs also in patients 
who do not have chronic cough. Enhanced sensitivity to environmental factors has also been 
linked to chronic cough in rhinosinusitis (Millquist & Bende, 2006). 
The analysis of the mechanisms triggering cough in rhinitis is further complicated by the 
fact that rhinosinusitis often coexists with other common causes of chronic cough such as 
gastroesophageal reflux disease and eosinophilic airway diseases including asthma. Thus 
the potential cough triggers may be unrelated to the nasal disease (discussed elsewhere in 
this issue). Rhinitis is also very often part of the asthma presentation (Togias, 2003) and 
chronic sinusitis and postnasal drip can be caused or worsen by gastroesophageal reflux 
(Poelmans & Tack, 2005) introducing even more complexity into the analysis. 
Treatment aimed at rhinosinusitis improves chronic cough in many patients who also 
present with other conditions potentially causing chronic cough (i.e. asthma or GERD). That 
the rhinosinusitis causes cough reflex hypersensitivity may explain the beneficial effect of 
this therapy. We speculate that the cough reflex hypersensitivity in combination with one or 
more cough triggers results in some unfortunate individuals in clinically relevant coughing 
termed chronic cough associated with rhinitis (Tatar et al., 2009). 
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